Mäkelä, Jyrki K <br/><br/>
Starting or switching to biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes: a multicenter, observational, primary care study conducted in Finland.  [electronic resource] 

 -  Diabetes research and clinical practice  Jan 2012 
 - 10-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8227 
<br/><br/><label>Standard No.: </label>10.1016/j.diabres.2011.06.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biphasic Insulins--administration & dosage<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Finland<br/>Follow-Up Studies<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin Aspart--administration & dosage<br/>Insulin, Isophane--administration & dosage<br/>Male<br/>Middle Aged<br/>Primary Health Care<br/>Treatment Outcome